Big Data for outcomes and clinical research:

major advance or improvement needed

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Creation of Big Data repositories is now emphasized at virtually all research institutions and the NIH, but the number of publications describing patient outcomes from these sources appears modest.1 Why is this so; what factors limit what should be a hugely productive resource, and how can we improve the impact of this use of Big Data? Why does this issue require greater physician engagement and understanding to solve? The integration of clinical, laboratory, and financial data is required to describe disease and treatment outcomes as well as treatment value.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Roy B. Jones
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
Amar Chahal
Chief operating officer, Velos Inc.
Dianne Reeves, MD
Retired associate director, Center for Biomedical Informatics and Information Technology, NCI
Gregory H. Jones
Resident, University of Texas School of Medicine
Charles S. Martinez
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
Table of Contents

YOU MAY BE INTERESTED IN

Growing up in inner-city Detroit, Otis Brawley had a thriving community made up of his parents, Jesuit priests, friends, and neighbors encouraging him that he could do anything he put his mind to. 
On Feb. 3, the House of Representatives passed the Senate Amendment to H.R. 7148, the Consolidated Appropriations Act, 2026, by a vote of 217 to 214. Later that day, President Donald Trump signed the bill into law, officially ending the brief partial government shutdown that began on Jan. 31. 
Roy B. Jones
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
Amar Chahal
Chief operating officer, Velos Inc.
Dianne Reeves, MD
Retired associate director, Center for Biomedical Informatics and Information Technology, NCI
Gregory H. Jones
Resident, University of Texas School of Medicine
Charles S. Martinez
Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login